Similar articles

• Pulmonary arterial hypertension: evaluation and management.

  LaRaia AV, Waxman AB. LaRaia AV, et al. South Med J. 2007 Apr;100(4):393-9. doi: 10.1097/SMJ.0b013e31802f2ff1. South Med J. 2007. PMID: 17458400 Review.
• Pulmonary arterial hypertension.

  Wu SC, Caravita S, Lisi E, Pierini S, Dadone V, Todd SE, Gentile F, Secchi MB. Wu SC, et al. Intern Emerg Med. 2009 Dec;4(6):459-70. doi: 10.1007/s11739-009-0263-2. Intern Emerg Med. 2009. PMID: 19504164
• [Endothelin receptor antagonists in the new European guidelines on pulmonary hypertension].

  Montani D, Humbert M. Montani D, et al. Rev Mal Respir. 2010 Feb;27(2):103-5. doi: 10.1016/j.rmr.2009.12.007. Epub 2010 Jan 25. Rev Mal Respir. 2010. PMID: 20206056 French. No abstract available.
• [Update: Current clinical developments in pulmonary hypertension].

  Dumitrescu D, Ghofrani HA, Grimminger F, Hoeper MM, Rosenkranz S. Dumitrescu D, et al. Dtsch Med Wochenschr. 2009 Aug;134 Suppl 5:S160-3. doi: 10.1055/s-0029-1225314. Epub 2009 Aug 28. Dtsch Med Wochenschr. 2009. PMID: 19718605 Review. German.
• [Pulmonary arterial hypertension related to systemic sclerosis in 2008].

  Agard C, Haloun A, Hamidou MA. Agard C, et al. J Mal Vasc. 2009 Feb;34(1):7-15. doi: 10.1016/j.jmv.2008.10.008. Epub 2008 Dec 9. J Mal Vasc. 2009. PMID: 19081217 Review. French.